English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial

MPS-Authors
/persons/resource/persons182138

Ehrenreich,  Hannelore
Clinical neuroscience, Max Planck Institute of Experimental Medicine, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Miskowiak, K. W., Ehrenreich, H., Christensen, E. M., Kessing, L. V., & Vinberg, M. (2014). Recombinant human erythropoietin to target cognitive dysfunction in bipolar disorder: a double-blind, randomized, placebo-controlled phase 2 trial. Journal of Clinical Psychiatry, 75(12): 10.4088/JCP.13m08839, pp. 1347-1355. doi:10.4088/JCP.13m08839.


Cite as: http://hdl.handle.net/11858/00-001M-0000-002A-F715-7
Abstract
There is no abstract available